June 2011 Latest Head & Neck Updates from ASCO

Published: Mon Jun 20, 2011 Updated:Wed Sep 14, 2011

We would like to thank Dr Stephanie Snow for the latest updates.

A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC).

Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC)

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin and paclitaxel in anaplastic thyroid cancer (ATC):  Final survival analysis for the FACT trial 

Sign-up for Our E-Newsletter